Financial Statements — FSHPR
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 |
|---|
| Cash & Equivalents | 0.00 | 0.02 | 0.02 | 0.04 | 0.00 | 0.11 |
| Total Current Assets | 0.02 | 0.05 | 0.08 | 0.16 | 0.12 | 0.24 |
| Total Non-current Assets* | 33.43 | 32.58 | 72.28 | 71.54 | 69.99 | 69.10 |
| Total Assets | 33.45 | 32.64 | 72.37 | 71.70 | 70.11 | 69.34 |
| Total Current Liabilities | 1.65 | 1.21 | 0.94 | 0.86 | 0.33 | 0.04 |
| Total Non-current Liabilities* | 1.73 | 1.73 | 1.73 | 1.73 | 1.73 | 1.73 |
| Total Liabilities | 3.37 | 2.93 | 2.66 | 2.58 | 2.05 | 1.77 |
| Retained Earnings | (3.36) | (2.88) | (2.58) | (2.43) | (1.93) | (1.53) |
| Total Stockholder Equity | (3.35) | (2.88) | (2.58) | (2.43) | (1.93) | (1.53) |
* Derived from reported values
Income Statement
(in thousands USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 |
|---|
| Selling, General & Admin | 130.63 | 107.75 | 236.60 | 152.65 | 162.07 | 332.52 | 402.97 | 78.02 |
| Pretax Income | 159.83 | 208.08 | 453.50 | 589.63 | 577.70 | 477.38 | 488.33 | 19.92 |
| Net Income | 159.83 | 208.08 | 453.50 | 589.63 | 577.70 | 477.38 | 488.33 | 19.92 |
| Basic EPS | 0.03 | -- | -- | -- | -- | -- | -- | -- |
| Diluted EPS | 0.03 | -- | -- | -- | -- | -- | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 |
|---|
| Operating Cash Flow | (0.03) | (0.08) | (0.15) | (0.07) | (0.18) | (0.24) | (0.41) | (0.22) |
| Investing Cash Flow | (0.06) | (0.18) | 40.39 | -- | -- | 0.00 | 0.00 | (69.00) |
| Financing Cash Flow | 0.09 | 0.25 | (40.24) | 0.05 | 0.14 | 0.32 | 0.31 | 69.21 |
